Innovation Hub
Advances in Ventilation and Perfusion (VQ) Assessment in COPD, CTEPH and Other Chronic Pulmonary Vascular Disorders
Innovation Hub 4
Sponsored by 4D Medical
Loading view.
Industry Theater
Should We Be Targeting Eosinophils Regardless of Allergic Status in Patients With Severe Eosinophilic Asthma?
Innovation Theater 2
Sponsored by GSK
Featured Innovation Hub
Elevating Asthma Control: Implications for Your Pediatric Patients
Innovation Hub 1
Sponsored by sanofi | regeneron
Industry Theater
Implementing Treprostinil Induction Strategies in Pulmonary Arterial Hypertension
Innovation Theater 1
Sponsored by United Therapeutics
Innovation Hub
Embracing the Changes: New Horizons in Asthma Clinical Trials
Innovation Hub 4
Sponsored by Parexel
Innovation Hub
How Methapharm Leverages Market Data for Strategic Growth
Innovation Hub 3
Sponsored by AcuityMD
Innovation Hub
EVIS X1 with Prof. Felix Herth, MD
Innovation Hub 1
Sponsored by Olympus America Inc
Industry Theater
A Brief Review of Clinical Insights for Identifying and Managing Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Innovation Theater 2
Sponsored by GSK
Industry Theater
Navigating RSV in Adults: Insights into Disease and Vaccination
Innovation Theater 3
Sponsored by GSK
Industry Theater
How Would You Address Eosinophilic + Allergic Inflammation in Severe Asthma?
Innovation Theater 5
Sponsored by Amgen/AstraZeneca
Innovation Hub
Challenges in Diagnosing Refractory Chronic Cough
Innovation Hub 2
Sponsored by GSK
Innovation Hub
Clearing the air: Navigating the diagnosis and management of Bronchiolitis obliterans syndrome (BOS) after lung transplant
Innovation Hub 4
Sponsored by Zambon USA Ltd.
Featured Industry Theater
Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management
Innovation Theater 4
Sponsored by Savara Inc.
Industry Theater
Disease Characteristics, Treatments, and Outcomes: Recent Findings From a Large, Real-World, PAH Drug Registry
Innovation Theater 1
Sponsored by Johnson & Johnson
Featured Innovation Hub
Tools of the Trade: Imaging in ILD
Innovation Hub 3
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Innovation Hub
The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on inflammation
Innovation Hub 1
Sponsored by Verona Pharma Inc
Evening Symposium
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understanding Disease Burden, Diagnosing Early, and Looking Toward New Management Options
Marriott Marquis – Marina Ballroom F/G
Sponsored by PVI, PeerView Institute for Medical Education
Supported by an educational grant from Insmed
Evening Symposium
Asymmetrical Nasal High Flow: A New Paradigm in Noninvasive Respiratory Support
Manchester Grand Hyatt – Seaport Ballroom
Sponsored by Fisher & Paykel Healthcare
Evening Symposium
Epithelial Cytokines: Connecting the Dots in Severe Asthma, Nasal Polyps, and COPD
Hilton Bayfront – Indigo Ballroom
Sponsored by Amgen/AstraZeneca
Evening Symposium
Approaches to COPD care: Targeting the ST2 receptor and IL-33 pathway as a potential option for patients at risk of exacerbating
Hilton Bayfront – Sapphire Ballroom
Sponsored by Genentech, A Member of the Roche Group
Evening Symposium
A Recent Development for Adults with Pulmonary Arterial Hypertension
Manchester Grand Hyatt – Grand Hall
Sponsored by Merck & Co., Inc.
Featured Industry Theater
Asthma Drivers of Disease: the effects of IL-5 on eosinophils and other cell types that contribute to airway remodeling and disease progression.
Innovation Theater 1
Sponsored by GSK
Industry Theater
New Insights Into Triple Therapy for COPD: A Focus on the Latest Real-World Evidence
Innovation Theater 3
Sponsored by GSK
Featured Industry Theater
Interstitial Lung Disease: Presentation to Patient Experience
Innovation Theater 5
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Innovation Hub
Treating hyperinflammation as an unmet need in CAP: Investigational agent reparixin and the REPAVID-22 trial
Innovation Hub 3
Sponsored by Dompe
Innovation Hub
Bronchoscopic Lung Volume Reduction: High Volume Community Hospital Perspective with Jason Stienecker, DO
Innovation Hub 1
Sponsored by Olympus America Inc.
Industry Theater
AIRSUPRA® (albuterol 90 mcg/budesonide 80 mcg): A Paradigm Shift
Innovation Theater 4
Sponsored by Amgen/AstraZeneca
Featured Innovation Hub
Earlier Assessment of Uncontrolled Moderate-to-Severe Asthma. Is There More We Can Do?
Innovation Hub 2
Sponsored by sanofi | regeneron
Innovation Hub
The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on bronchoconstriction
Innovation Hub 4
Sponsored by Verona Pharma Inc
Industry Theater
Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium
Innovation Theater 2
Sponsored by Theravance Biopharma US, Inc
Innovation Hub
VERITAS RCT: Has bronchoscopy finally replaced CT-Guided biopsy?
Innovation Hub 3
Sponsored by Medtronic
Innovation Hub
Veterans in Crisis: Uncovering the Realities of Burn Pit Exposure and DRRD
Innovation Hub 1
Sponsored by 4D Medical
Industry Theater
Choose Wisely: ACT™ or AIRQ®?
Innovation Theater 1
Sponsored by Amgen/AstraZeneca
Innovation Hub
Ambulation and Long-Term Oxygen Therapy
Innovation Hub 2
Sponsored by Inogen
Innovation Hub
Incidental Findings: Identifying cancers earlier
Innovation Hub 1
Sponsored by Softek Illuminate
Industry Theater
Breathing Innovation: Inhaled Pirfenidone for the Treatment of Progressive Pulmonary Fibrosis
Innovation Theater 2
Sponsored by Avalyn Pharma
Featured Industry Theater
Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation – Is it the Time for Precision Medicine in COPD?
Innovation Theater 3
Sponsored by GSK
Featured Industry Theater
Clinical Considerations for Sleep Specialists on the Improvement of Wakefulness in Patients With Excessive Daytime Sleepiness
Innovation Theater 5
Sponsored by Axsome Therapeutics, Inc.
Innovation Hub
The Role of Single-Use Bronchoscopes in the Bronch Lab with Sonali Sethi, MD
Innovation Hub 2
Sponsored by Olympus America Inc.
Innovation Hub
The Healthcare of Today, Looking towards Tomorrow: Digital Innovations and Patient-Centricity
Innovation Hub 4
Sponsored by ResMed
Industry Theater
COPD and Asthma with Type 2 Inflammation: Distinct Diseases with a Shared Cause
Innovation Theater 4
Sponsored by sanofi | regeneron
Featured Evening Symposium
Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
Manchester Grand Hyatt – Seaport Ballroom FGH
Sponsored by sanofi | regeneron
Featured Evening Symposium
Exploring the Impact of OFEV® (nintedanib) capsules
Marriott Marquis – Marina Ballroom F/G
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Evening Symposium
Pulmonary Arterial Hypertension Gameshow
Hilton Bayfront – Sapphire Ballroom
Sponsored by MedScape
Supported by an independent educational grant from Actelion, a Janssen Pharmaceutical Company of Johnson and Johnson, and Merck & Co., Inc.
Evening Symposium
Applying Newer Diagnostic and Therapeutic Tools to the Management of the Individual with Nontuberculous Mycobacterial Lung Disease
Manchester Grand Hyatt – Grand Hall
Sponsored by Med Learning Group
Supported by an educational grant from Insmed
Evening Symposium
An Expert Panel on Severe Asthma: From the Epithelium to Better Patient Outcomes
Hilton Bayfront – Indigo Ballroom
Sponsored by Integritas Communications
Supported by an educational grant from AstraZeneca
Industry Theater
Navigating the COPD Patient Journey With Nebulized Maintenance Therapy
Innovation Theater 2
Sponsored by Viatris | Theravance Biopharma
Featured Industry Theater
Expectations for Oral Corticosteroid Use
Innovation Theater 3
Sponsored by sanofi | regeneron
Industry Theater
The Importance of a Proactive Approach to the Management of COPD
Innovation Theater 5
Sponsored by AstraZeneca
Innovation Hub
Postoperative Prolonged Air Leaks with the Spiration Valve System, Roy Cho, MD
Innovation Hub 1
Sponsored by Olympus America Inc.
Industry Theater
Building on Foundational Pathways: A New Treatment Option for PAH
Innovation Theater 4
Sponsored by Johnson & Johnson
Featured Industry Theater
Holistic Care of the Immunocompromised Pulmonary Patient with EGPA
Innovation Theater 2
Sponsored by GSK
Industry Theater
Emerging Pathways to Precision Medicine for Alpha-1 Antitrypsin Deficiency
Innovation Theater 1
Sponsored by Takeda
Innovation Hub
The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on mucociliary dysfunction
Innovation Hub 2
Sponsored by Verona Pharma Inc
Industry Theater
Understanding EGPA and the Role of Eosinophilic Inflammation
Innovation Theater 3
Sponsored by Amgen/AstraZeneca
Industry Theater
Ignite New Thinking in COPD: Exploring Type 2 Inflammation
Innovation Theater 5
Sponsored by sanofi | regeneron
Industry Theater
Global Health Inequities in Chronic Respiratory Disease: Challenges and Potential Solutions
Innovation Theater 4
Sponsored by Chiesi USA
Industry Theater
Machine Learning and Fibrosing Lung Disease: Imaging Biomarker Progress – with Dr. Simon Walsh and Dr. Kevin Brown, moderated by Elizabeth Estes
Innovation Theater 1
Sponsored by Open Source Image Consortium
Evening Symposium
PATHWAYS in Type 2 Inflammation Global Grant Initiative
Manchester Grand Hyatt – Seaport Ballroom
Sponsored by sanofi | regeneron
Evening Symposium
Surv.AI Says: Real-World Insights into the Journey for Patients with Pulmonary Arterial Hypertension
Marriott Marquis – Marina Ballroom F/G
Sponsored by Physicians’ Education Resource, LLC
Supported by an educational grant from Merck & Co., Inc.